Mark Sulkowski
Johns Hopkins University · 616 works · 48,099 citations · h-index 92
Top works
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus Infection
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
- Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
- Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections
- Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
- Role of liver biopsy in management of chronic hepatitis C: A systematic review
- Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- Hepatitis C and Progression of HIV Disease
- Needlestick Injuries among Surgeons in Training
- Hepatitis C in the HIV-Infected Person